Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells
- 1 December 2000
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 130 (6) , 774-781
- https://doi.org/10.1016/s0002-9394(00)00772-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Sustained transgene expression in vitro and in vivo using an Epstein–Barr virus replicon vector system combined with HVJ liposomesGene Therapy, 1998
- Clinicopathological correlation of primary and recurrent choroidal neovascularisation following surgical excision in age related macular degenerationBritish Journal of Ophthalmology, 1998
- Development and Characterization of Cationic Liposomes Conjugated with HVJ (Sendai Virus): Reciprocal Effect of Cationic Lipid forIn VitroandIn VivoGene TransferHuman Gene Therapy, 1997
- Cloning and expression of the cDNA encoding rat tissue inhibitor of metalloproteinase 3 (TIMP-3)Gene, 1996
- A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growthBiochemistry and Cell Biology, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophyNature Genetics, 1994
- Transmembrane organization of the sodium-potassium-ATPase determined by epitope additionBiochemistry, 1993
- The matrix‐degrading metalloproteinasesBioEssays, 1992
- Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cellsNature, 1985